{
  "id": 9768990,
  "title": "Merck expands Welireg's use to broader set of kidney cancer patients",
  "url": "https://urgent.news/2026/09/25/merck-expands-weliregs-use-to-broader-set-of-kidney-cancer-patients",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-25T12:37:47.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/merck-expands-weliregs-use-to-broader-set-of-kidney-cancer-patients/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Merck’s Welireg won FDA approval on Friday for use in combination with Eisai’s Lenvima to treat certain kidney cancer patients. The combination will be available to patients with advanced renal cell carcinoma with a clear ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}